Pathway Therapeutics

- PRIVATE:PATHWAYTHERAPEUTICS
  • About

    Pathway Therapeutics develops selective inhibitors of PI3-kinase and mTOR for the treatment of cancer and inflammatory diseases.
  • Domains

  • Locations

    • San Francisco CA
  • Total Funding (USD)

    24.0 million

Request a demo to view additional historical data, and much more.